CN111053716B - Application of Fuzhuan tea extract in preparation of skin conditioning product - Google Patents
Application of Fuzhuan tea extract in preparation of skin conditioning product Download PDFInfo
- Publication number
- CN111053716B CN111053716B CN201911306311.XA CN201911306311A CN111053716B CN 111053716 B CN111053716 B CN 111053716B CN 201911306311 A CN201911306311 A CN 201911306311A CN 111053716 B CN111053716 B CN 111053716B
- Authority
- CN
- China
- Prior art keywords
- extract
- tea extract
- fuzhuan
- tea
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 263
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 38
- 241001122767 Theaceae Species 0.000 title claims abstract 13
- 238000002360 preparation method Methods 0.000 title claims description 19
- 241000186427 Cutibacterium acnes Species 0.000 claims abstract description 23
- 239000002537 cosmetic Substances 0.000 claims abstract description 23
- 229940055019 propionibacterium acne Drugs 0.000 claims abstract description 23
- 230000004054 inflammatory process Effects 0.000 claims abstract description 20
- 206010061218 Inflammation Diseases 0.000 claims abstract description 19
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 15
- 206010000496 acne Diseases 0.000 claims abstract description 15
- 239000002417 nutraceutical Substances 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 230000000694 effects Effects 0.000 claims description 44
- 239000000843 powder Substances 0.000 claims description 28
- 230000001965 increasing effect Effects 0.000 claims description 17
- 239000000287 crude extract Substances 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 229940088598 enzyme Drugs 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 102000004139 alpha-Amylases Human genes 0.000 claims description 3
- 108090000637 alpha-Amylases Proteins 0.000 claims description 3
- 229940024171 alpha-amylase Drugs 0.000 claims description 3
- 238000004061 bleaching Methods 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000037394 skin elasticity Effects 0.000 abstract description 15
- 230000002708 enhancing effect Effects 0.000 abstract description 12
- 230000009471 action Effects 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 7
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 description 254
- 235000013616 tea Nutrition 0.000 description 246
- 210000003491 skin Anatomy 0.000 description 98
- 239000000047 product Substances 0.000 description 61
- 230000014509 gene expression Effects 0.000 description 53
- 210000002510 keratinocyte Anatomy 0.000 description 46
- 230000003712 anti-aging effect Effects 0.000 description 42
- 239000001963 growth medium Substances 0.000 description 34
- 239000000243 solution Substances 0.000 description 34
- 210000003780 hair follicle Anatomy 0.000 description 31
- 239000000428 dust Substances 0.000 description 30
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 27
- 235000020339 pu-erh tea Nutrition 0.000 description 27
- 239000002609 medium Substances 0.000 description 24
- 239000006210 lotion Substances 0.000 description 23
- -1 alkaloid compounds Chemical class 0.000 description 22
- 230000037303 wrinkles Effects 0.000 description 20
- 210000002950 fibroblast Anatomy 0.000 description 19
- 108090000765 processed proteins & peptides Proteins 0.000 description 19
- 238000000034 method Methods 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 108010035532 Collagen Proteins 0.000 description 15
- 102000008186 Collagen Human genes 0.000 description 15
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 15
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 15
- 229920001436 collagen Polymers 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 14
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 241001205401 Aspergillus cristatus Species 0.000 description 12
- 244000025272 Persea americana Species 0.000 description 12
- 235000008673 Persea americana Nutrition 0.000 description 12
- 230000003255 anti-acne Effects 0.000 description 12
- 238000009472 formulation Methods 0.000 description 11
- 230000005764 inhibitory process Effects 0.000 description 11
- 239000000865 liniment Substances 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 229940040145 liniment Drugs 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 9
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 8
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 8
- 102000004125 Interleukin-1alpha Human genes 0.000 description 8
- 108010082786 Interleukin-1alpha Proteins 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 210000002374 sebum Anatomy 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000000699 topical effect Effects 0.000 description 8
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 7
- 201000004384 Alopecia Diseases 0.000 description 7
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 7
- 108090000193 Interleukin-1 beta Proteins 0.000 description 7
- 241000219745 Lupinus Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 7
- 235000000484 citronellol Nutrition 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000007689 inspection Methods 0.000 description 7
- 230000002438 mitochondrial effect Effects 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- 102000003777 Interleukin-1 beta Human genes 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 229910002091 carbon monoxide Inorganic materials 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000003410 keratolytic agent Substances 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 230000009759 skin aging Effects 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 6
- 230000004936 stimulating effect Effects 0.000 description 6
- 230000002407 ATP formation Effects 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 231100000360 alopecia Toxicity 0.000 description 5
- 235000014121 butter Nutrition 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 229940106189 ceramide Drugs 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000001143 conditioned effect Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000002356 single layer Substances 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- 235000018553 tannin Nutrition 0.000 description 5
- 239000001648 tannin Substances 0.000 description 5
- 229920001864 tannin Polymers 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 4
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 108010053835 Catalase Proteins 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 102000005867 Fibrillin-1 Human genes 0.000 description 4
- 108010030229 Fibrillin-1 Proteins 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 4
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 4
- 235000000421 Lepidium meyenii Nutrition 0.000 description 4
- 240000000759 Lepidium meyenii Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 235000008599 Poria cocos Nutrition 0.000 description 4
- 244000197580 Poria cocos Species 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
- 235000019486 Sunflower oil Nutrition 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000002514 epidermal stem cell Anatomy 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 238000003633 gene expression assay Methods 0.000 description 4
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000012902 lepidium meyenii Nutrition 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 239000002516 radical scavenger Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000002600 sunflower oil Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical class C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 3
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
- 240000006162 Chenopodium quinoa Species 0.000 description 3
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 3
- 102000012432 Collagen Type V Human genes 0.000 description 3
- 108010022514 Collagen Type V Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 description 3
- 102100038055 Glutathione S-transferase theta-1 Human genes 0.000 description 3
- 102100033039 Glutathione peroxidase 1 Human genes 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 101001032462 Homo sapiens Glutathione S-transferase theta-1 Proteins 0.000 description 3
- 101001014936 Homo sapiens Glutathione peroxidase 1 Proteins 0.000 description 3
- 101001045846 Homo sapiens Histone-lysine N-methyltransferase 2A Proteins 0.000 description 3
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 3
- 101001124867 Homo sapiens Peroxiredoxin-1 Proteins 0.000 description 3
- 229940124091 Keratolytic Drugs 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 3
- 102100029139 Peroxiredoxin-1 Human genes 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 102100036407 Thioredoxin Human genes 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229940061720 alpha hydroxy acid Drugs 0.000 description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000003429 antifungal agent Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000011449 brick Substances 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 238000003501 co-culture Methods 0.000 description 3
- 239000000498 cooling water Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000021995 interleukin-8 production Effects 0.000 description 3
- 239000002085 irritant Substances 0.000 description 3
- 230000001530 keratinolytic effect Effects 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical class CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 210000001626 skin fibroblast Anatomy 0.000 description 3
- 229950011392 sorbitan stearate Drugs 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000016804 zinc Nutrition 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- 244000235603 Acacia catechu Species 0.000 description 2
- 239000001904 Arabinogalactan Substances 0.000 description 2
- 229920000189 Arabinogalactan Polymers 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- 108010087806 Carnosine Proteins 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 2
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000169203 Eichhornia Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 2
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- 235000010649 Lupinus albus Nutrition 0.000 description 2
- 240000000894 Lupinus albus Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000001188 Peltandra virginica Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 235000019312 arabinogalactan Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940110716 cicatrizants Drugs 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 229940108928 copper Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 235000007882 dietary composition Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000019225 fermented tea Nutrition 0.000 description 2
- 102000013370 fibrillin Human genes 0.000 description 2
- 108060002895 fibrillin Proteins 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000021189 garnishes Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002973 irritant agent Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 2
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229940081510 piroctone olamine Drugs 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 208000009056 telangiectasis Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LKLYETYHDMXRAF-UHFFFAOYSA-N 2-octanoyloxybenzoic acid Chemical compound CCCCCCCC(=O)OC1=CC=CC=C1C(O)=O LKLYETYHDMXRAF-UHFFFAOYSA-N 0.000 description 1
- VSDNNWKISVRDNT-UHFFFAOYSA-N 2-octoxybenzoic acid Chemical compound CCCCCCCCOC1=CC=CC=C1C(O)=O VSDNNWKISVRDNT-UHFFFAOYSA-N 0.000 description 1
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 235000006020 Acacia catechu Nutrition 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000093727 Berzelia alopecuroides Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 241000168096 Glareolidae Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 241000208681 Hamamelis virginiana Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 101000604197 Homo sapiens Neuronatin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000480130 Liusus Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 108010091175 Matriptase Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 101100233797 Mus musculus Krt18 gene Proteins 0.000 description 1
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 description 1
- 102100038816 Neuronatin Human genes 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000011552 Rhamnus crocea Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 102100037942 Suppressor of tumorigenicity 14 protein Human genes 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- 241000222433 Tricholomataceae Species 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- XDLGATIAMPGERU-UHFFFAOYSA-N [2-[[4-[[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanyl]methyl]phenyl]methyl]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2CC(C=C1)=CC=C1CC1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C XDLGATIAMPGERU-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000001560 acacia catechu Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940083712 aldosterone antagonist Drugs 0.000 description 1
- 239000002170 aldosterone antagonist Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000003367 anti-collagen effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229940024874 benzophenone Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 235000014541 cooking fats Nutrition 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 229960000860 dapsone Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical group C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229920001461 hydrolysable tannin Polymers 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical class CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229940106134 krill oil Drugs 0.000 description 1
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000008519 pasta sauces Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229940084038 salix alba bark extract Drugs 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229910000338 selenium disulfide Inorganic materials 0.000 description 1
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N selenium sulfide Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940058349 sodium levulinate Drugs 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000014348 vinaigrettes Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses application of a Fuzhuan tea extract in preparing a skin conditioning product, wherein the skin conditioning product comprises a skin care product, a cosmetic, a nutriceutical and a dermatological application product for resisting acne, resisting oxidation, resisting inflammation, resisting stimulation, resisting aging or enhancing skin elasticity. The Fuzhuan tea extract of the present invention is intended to inhibit inflammation by specific action against Propionibacterium acnes and therefore can be used for preparing skin conditioning products.
Description
Technical Field
The invention belongs to the technical field of medicines and health-care foods, and particularly relates to application of a Fuzhuan tea extract in preparation of a skin conditioning product.
Background
The Fu tea is a post-fermented tea which is prepared by using raw dark green tea or crude old green tea as a raw material and is reprocessed, belongs to one of dark green tea in six basic tea categories of China, and is also a fully fermented tea. Fu tea has a long history, and is called Fu tea because it is processed and prepared in summer overnight and has fragrance and action similar to that of Poria. The main form of the Fuzhuan tea is compressed tea, namely, in the manufacturing process, in order to facilitate transportation and storage, a producer compresses the Fuzhuan tea into a brick shape, so that the Fuzhuan tea looks like a brick, and is also named as the Fuzhuan tea. At present, the Fu tea is also sold in the forms of loose tea, cake tea and the like. Fu tea is mainly sold in areas of frontier regions such as Xinjiang, Gansu, Tibet and the like, is commonly called as 'side tea' or 'side selling tea', and is known as 'mystery tea on ancient silk roads' and 'black and gold on silk roads' in more than forty countries such as Zhongya, Western Asia and the like along the 'silk roads'.
Modern pharmacological research shows that the Fuzhuan tea has obvious health effects of promoting digestion, reducing blood fat, nourishing the stomach, losing weight, regulating carbohydrate metabolism, inhibiting tumor cells, enhancing immunity and the like. The tuckahoe tea can promote metabolism of human bodies, improve immunity, strengthen physique and delay senility after being drunk for a long time, and has obvious pharmacological health care and pathological prevention effects.
Research shows that the pharmacological activity of the Fuzhuan tea is the result of the combined action of the active ingredients of the tea and a dominant bacterium, namely Eurotium cristatum, which is naturally formed in the fermentation process. The eurotium cristatum plays an important role in the quality and the pharmacological effect of the Fu tea. Eurotium cristatum called as golden flower fungus in Fuzhuan tea, belongs to Eurotium cristatum of Tricholomataceae of Ascomycetales, and is suitable for growing in soil, Fuzhuan tea, Cordyceps, Chinese medicinal tablet and sawdust. Eurotium cristatum consists of ascocarp and hyphae. The eurotium cristatum can produce rich natural active ingredients, thereby endowing the Fuzhuan tea with unique color, fragrance and taste, and being the material basis of the Fuzhuan tea with the health-care effects of promoting digestion, reducing fat and losing weight, inhibiting tumor cells, treating cardiovascular diseases and the like. The eurotium cristatum also generates a large amount of special bioactive substances in the Fu tea in the process of co-fermentation of the Fu tea and the tea.
At present, there are many reports on the research of Fu tea. For example, the process of preparing instant black tea by liquid fermentation was reported by the lu courser (the master thesis of university of agriculture in Anhui, Eurotium cristatum, functional research thereof, and the director Yuepeng Xiang). Yuan Yong (thesis of Master academic thesis of Hunan agriculture university, the preliminary research on pharmacological efficacy and chemical components of Fuzhuan tea golden flower fungus extract, and the guiding teacher Liu Zhong Hua) reported the research on the extraction and separation of Eurotium cristatum spore powder. Eichhornia et al (Eichhornia, Liusu pure, Yuanqian, Zhao le, research on wall breaking method of Ascomyces guanfaciei ascospores, food and machinery 2011,27 (3): 137-. Lu et al (Advance Journal of Food Science and Technology 2016, 10 (8): 591-596.) reported the study of the active ingredients in Eurotium cristatum fermented black tea. Zou et al (Molecules 2014,19,17839-17847) reported alkaloid compounds produced by fermentation of Eurotium cristatum. Fu et al (Food Research International 2011, 44: 2999-3005.) report the mechanism of hypolipidemic activity of Fu tea. Yan et al (Food and Agricultural Immunology 2017, 28 (3): 388-402) report the effect and mechanism of Eurotium cristatum in Fuzhuan tea for activating immunity.
According to 26.09.2013, the original national quality inspection and quarantine bureau approves the geographical sign product protection of the Jingyang Fuzhuan tea, and the national quality supervision inspection and quarantine bureau announces that the quality inspection bureau approves the geographical sign product protection of the salt pond salt (river east salt), the salt pond black mud, the Jingyang Fuzhuan tea, the Yijun walnut and the Hongcuan wine (No. 137 in 2013) clearly requires the quality technology of the Fuzhuan tea, so that the subsequent research on the Fuzhuan tea is facilitated.
Disclosure of Invention
The invention aims to provide application of a Fuzhuan tea extract in preparing a skin conditioning product.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
in a first aspect of the invention, the invention provides a use of an extract of Fuzhuan tea in the preparation of a skin conditioning product.
The skin conditioning products include anti-acne, anti-oxidant, anti-inflammatory, anti-irritant, anti-aging, or skin elasticity enhancing skin care products, cosmetics, nutraceuticals, dermatological use products that are anti-acne or hair follicle enhancing, anti-alopecia, skin elasticity enhancing, anti-aging, or wrinkle removing dermatological use products.
The Fuzhuan tea extract refers to a water-soluble and/or fat-soluble extract. In other embodiments of the present invention, the fu tea extract refers to supercritical CO2Extract, organic solvent extract, aqueous extract or mixture thereof.
The organic solvent is ethanol.
The preparation method of the organic solvent extract comprises the following steps: grinding Fuzhuan tea into powder, wherein the diameter of the powder is not more than 0.5cm, adding 85% -95% ethanol into the Fuzhuan tea powder according to the solid-to-liquid ratio of 1:20(m/v), ultrasonically breaking the wall until no tea powder and thalli can be seen by naked eyes, then carrying out cold immersion for 18-28 hours, collecting filtrate, repeating for 2-5 times, carrying out reduced pressure distillation on the filtrate, concentrating the filtrate, drying at low temperature to obtain a crude extract, adsorbing and decoloring the crude extract by macroporous resin (AB-8 macroporous adsorption resin), eluting by 85% -95% ethanol, concentrating and drying by distillation, and carrying out low temperature freeze drying to obtain the organic solvent extract of the Fuzhuan tea.
The preparation method of the water extract comprises the following steps: grinding Fuzhuan tea into powder, wherein the diameter of the powder is not more than 0.5cm, adding water into the Fuzhuan tea powder according to the solid-to-liquid ratio of 1:10(m/v), uniformly stirring, ultrasonically breaking the wall until no tea powder and bacteria can be seen, standing for 2 hours at room temperature, and boiling for 2 hours in a boiling water bath to obtain a mixed solution; taking out the mixed solution, cooling, centrifuging at an ultra high speed, and taking the supernatant; filtering and sterilizing the supernatant with 0.22 μm filter membrane to obtain water extract of Fuzhuan tea. Concentrating and evaporating to dryness if necessary, and freeze-drying at low temperature.
The supercritical CO2The preparation method of the extract comprises the following steps: grinding Fuzhuan tea into powder with diameter not more than 0.5cm, completely crushing tea powder and thallus, adding water vapor for pre-soaking until water content is increased to 40%, placing the pre-soaked Fuzhuan tea powder into an extraction tank, and continuously feeding CO into the tank2Gradually extracting the crude extract with CO of the crude extract2Sending to a cleaning tank, allowing the Fuzhuan tea extract to enter water phase, and passing through supercritical CO2Extracting to obtain crude extract, hydrolyzing starch and fiber (cellulose, hemicellulose, etc.) with mixture of cellulase and alpha-amylase (concentration of 0.5% each), heating at 65 deg.C for 30 min to denature the enzyme, and centrifuging to remove impurities; removing residual protein (exudate) with 15kDa ultrafiltration column, bleaching extract with activated carbon and filtering and recovering, sterilizing the product with 0.2 μm filter membrane, and lyophilizing or packaging to obtain Fuzhuan tea supercritical CO2And (3) extracting.
The Fuzhuan tea extract of the invention is intended to inhibit inflammation through specific action against Propionibacterium acnes, so as to be used as a skin conditioning product, in particular as an anti-inflammatory drug or cosmetic for resisting inflammation of the skin.
The present inventors have found that the fu tea extract has cosmetic and dermatological uses that have not been described previously.
The fu tea extract of the present invention is a cosmetic, nutraceutical, or dermatological composition for treating or preventing acne comprising the fu tea extract in combination with a suitable excipient. The composition may also comprise at least one anti-acne substance selected from sebum regulators, antibacterial and/or antifungal agents, keratolytic and/or keratolytic agents, astringents, anti-inflammatory and/or anti-irritant agents, antioxidant and/or free radical scavengers, cicatrizants, anti-ageing agents or moisturizers. The present invention also relates to cosmetic methods of applying the compositions of the present invention to an area of skin affected by the condition, or orally administering the compositions of the present invention to an individual with the condition.
The skin conditioning product may be selected from the group consisting of products that inhibit inflammatory mediators in keratinocytes, products that inhibit gene expression of matrix proteases, products that inhibit VEGF synthesis and release in keratinocytes, products that promote cellular collagen expression, products that increase cellular fibrillin synthesis, products that maintain stem cells dry, products that stimulate stem cell proliferation, products that promote ATP synthesis or enhance mitochondrial metabolic activity in hair follicle papilla fibroblasts, products that increase cell viability of hair follicles or reduce damage to hair follicle membranes, products that increase expression of the skin antimicrobial peptide hBD3 by removing and eliminating toxins, products that inhibit active oxygen production (products that prevent skin problems caused by dust, such as inflammation, etc.).
The skin conditioning product takes the Fuzhuan tea extract as the only active component, or a pharmaceutical composition containing the Fuzhuan tea extract.
The pharmaceutical composition containing the Fuzhuan tea extract is a pharmaceutical composition consisting of the Fuzhuan tea extract and one or more pharmaceutically-allowable auxiliary materials.
The content of the Fuzhuan tea extract in the skin conditioning product is 0.1-99 wt%.
The content of the Fuzhuan tea extract in the skin conditioning product is 0.5-90 wt%.
The auxiliary material is at least one of diluent, excipient, adhesive, filler, disintegrating agent, flavoring agent and sweetener.
The Fuzhuan tea extract can be prepared into a medicinal preparation with a conventional pharmaceutic adjuvant in pharmaceutics.
The pharmaceutical preparation is at least one of a capsule, a suspension, a tablet, a powder, an emulsion, a solution, a syrup or an injection.
The administration mode of the pharmaceutical preparation is oral administration and injection.
In the description of the present invention, the fu tea is preferably jing yang fu tea which meets the quality and technical requirements for fu tea as described in the bulletin of the quality inspection and inspection bureau of the national quality supervision, inspection and quarantine bureau of the ministry of health and safety on the geographic marking product protection of salt pond (large salt in river east), black mud in salt pond in city, jing yang fu brick tea, lijun walnut and hong chuan wine (No. 137 in 2013).
The invention also comprises a composition containing the Fuzhuan tea extract as an active ingredient according to the type of application. The composition comprises at least one pharmaceutically acceptable excipient, in particular a dermatologically acceptable excipient. If the composition is a cosmetic or dermatological composition, excipients suitable for topical application in vitro are used.
The composition of the invention may also comprise at least one pharmaceutical adjuvant known to the person skilled in the art, selected from thickeners, preservatives, fragrances, colorants, chemical or mineral sunscreens, humectants, thermal spring water and the like.
The composition of the present invention may further comprise at least one anti-acne compound selected from sebum regulators, antibacterial agents, antifungal agents, keratolytic agents, cuticle regulators, astringent agents, anti-inflammatory/anti-irritant agents, antioxidant/free radical scavengers, cicatrizants, anti-ageing agents and/or moisturizers.
The term "sebum regulator" for example means an inhibitor of 5-alpha-reductaseSuch as active substancesZinc and its gluconate, salicylate and pyroglutamic acid salts also have sebum suppressive activity. Mention may also be made of spironolactone, an antiandrogen and an aldosterone antagonist, which significantly reduces the rate of sebum secretion after 12 weeks of application. Other extract molecules, such as seeds from Cucurbita pepo, pumpkin seed oil, and palmetto (palm cabbagage), limit sebum production by inhibiting 5-alpha-reductase transcription and activity. Other sebum regulators that affect sebum properties, such as linoleic acid, may also be used.
The terms "antibacterial agent" and "antifungal agent" refer to molecules that limit the growth or destroy pathogenic microorganisms, such as certain bacteria, such as propionibacterium acnes, or certain fungi (Malassezia furfur), the most traditional being preservatives commonly used in cosmetics or nutraceuticals, i.e. molecules with antibacterial activity (pseudopreservatives) such as caprylic acid derivatives (caprylylglycine, caprylin, etc.), such as hexylene glycol and sodium levulinate, zinc and copper derivatives (gluconate and PCA), phytosphingosine and its derivatives, benzoyl peroxide, piroctone olamine, zinc pyrithione, selenium disulfide, econazole, ketoconazole, or topical antibiotics such as erythromycin and clindamycin, etc.
The terms "keratolytic agent" and "keratolytic agent" refer to a substance that modulates or assists in the elimination of dead cells of the stratum corneum of the epidermis. Commonly used keratolytic/keratolytic agents include: the most commonly used keratolytic/keratolytic agents include: alpha-hydroxy acids (AHAS) of fruits (citric acid, glycolic acid, malic acid, lactic acid, etc.), AHA esters, combinations of AHAS with other molecules such as malic acid and almond proteinA combination of glycolic or lactic acid and arginine or a hydroxy acid and a lipid molecule such as(lipid-hydroxy acids), amphoteric hydroxy acid complexes (AHCare), willow bark (white willow bark extract), azelaic acid and its salts and esters, salicylic acid and its derivatives such as octanoylsalicylic acid or in combination with other molecules such as salicylic acid and polysaccharides (beta-hydroxy acids or BHA), tazarotene, adapalene, and molecules of retinoids such as tretinoin, retinal, isotretinoin, and retinol.
The term "astringent" refers to a substance that helps narrow pores, most commonly used are polyphenols, zinc derivatives, and hamamelis virginiana.
The term "anti-inflammatory/anti-irritant" refers to a substance that limits the inflammatory response caused by cytokines or arachidonic acid metabolic mediators and has smooth and anti-irritant properties. Most conventional are glycyrrhetinic acid (glycyrrhiza derivative) and its salts and esters, alpha-bisabolol, Ginkgo biloba (Ginkgo biloba), marigold (calenula), lipoic acid, beta-carotene, vitamin B3 (niacinamide), vitamin E, vitamin C, vitamin B12, flavonoids (green tea, quercetin, etc.), lycopene or lutein, avocado sugar, avocado oil essence (avocado oleodestillate), arabinogalactan, lupin peptide, lupin total extract, quinoa peptide extract, cyclic ceramide(oxazoline derivatives), anti-glycation agents such as carnosine, N-acetylcysteine, isoflavones such as genistein/genistin, daidzein/daidzin, spring water or spa water (eau d 'Avene), beauty care spring (eau de la Roche Posay), Saint Fang Wei (eau de Saint Gervais), You d' Uriage, Kerd (eau de Gamarde), Lycium barbarum extract, vegetarian amino acid peptides or compounds, topical dapsone, or anti-inflammatory agents.
The term "antioxidant/radical scavenger" refers to a molecule that reduces or prevents the oxidation of other chemicals. The antioxidant/radical scavenger that may be used in combination is preferably selected from the group consisting of: mercaptan and phenol, Glycyrrhrizae radix derivatives such as glycyrrhetinic acid and its salt and ester, alpha-bisabolol, semen Ginkgo extract, and herba Sidae Rhombifoliae (Calendu)la) extract, cyclic ceramide(oxazoline derivatives), avocado peptides, trace elements such as copper, zinc and selenium, lipoic acid, vitamin B12, vitamin B3 (niacinamide, nigulamide), vitamin C, vitamin E, coenzyme Q10, krill oil (krill), glutathione, Butylated Hydroxytoluene (BHT), Butylated Hydroxyanisole (BHA), lycopene or lutein, beta-carotene, polyphenol families such as tannins, phenolic acids, anthocyanins, flavonoids such as green tea, red berries, cocoa, grapes, passion fruit (pasiflora incarnata) or Citrus (Citrus) extracts, or isoflavones such as genistein/genistin and daidzein/daidzin. The antioxidant group also includes anti-glycation agents such as carnosine or certain peptides, N-acetylcysteine, and antioxidant or free radical scavenging enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase, thioredoxin reductase, and antagonists thereof.
Substances which can be used in combination for scar formation/repair barrier function are preferably vitamin a, panthenol (vitamin B5),Lupeol, maca peptide extract, quinoa peptide extract, arabinogalactan, zinc oxide, magnesium, silicon, madecassic or asiatic acid, dextran sulfate, coenzyme Q10, glucosamine and derivatives thereof, chondroitin sulfate and total glycosaminoglycans (GAGs), dextran sulfate, ceramides, cholesterol, squalane, phospholipids, fermented or unfermented soybean peptides, plant peptides, marine polysaccharides, plant polysaccharides or biotechnological polysaccharides, such as algae extracts or fern extracts, trace elements, extracts of tannin-rich plants such as tannins derived from gallic acid, known as indigestible tannins or hydrolysable tannins, originally found in oak galls, and catechin tannins resulting from the polymerization of flavan units, models of which are provided by the catechu (Acacia catechu). The trace elements which may be used are preferably selected from the group consisting of copper, magnesium, manganese, chromium, selenium, silicon, zinc and mixtures thereofThe group (2).
Anti-aging agents which can be used in combination to treat acne in mature subjects are antioxidants, in particular vitamin C, vitamin A, retinol, retinal, hyaluronic acid of any molecular weight, alpha-linolenic acid, beta-linolenic acid, and beta-linolenic acid,Lupin peptide and maca peptide extracts.
The most commonly used humectants/emollients are glycerin or its derivatives, urea, pyrrolidone carboxylic acid and its derivatives, hyaluronic acid of any molecular weight, glycosaminoglycans and any other polysaccharides of marine, vegetable or biotechnological origin, such as xanthan gum, and mixtures thereof,Certain fatty acids such as lauric, myristic, monounsaturated and polyunsaturated omega-3, -6, -7 and-9 fatty acids (linoleic, palmitoleic, etc.), sunflower oil essence (sunflower oleodestillate), avocado peptide and cupuacu butter (cupuacu butter).
In some preferred embodiments of the invention, the extract of hoechuan tea of the invention may be used as a skin conditioning product in combination with a plant or animal unsaponifiable composition, for example, avocado and soybean unsaponifiables and unsaponifiable vegetable oils or animal oil concentrates, for example, sunflower oil or palm oil concentrates, or unsaponifiable-containing vegetable oils, for example, soybean oil and rapeseed oil, and unsaponifiable derivatives such as avocado furan, sterol esters and vitamin derivatives.
In some preferred embodiments of the present invention, the extract of Fuzhuan tea of the present invention may be used as a skin conditioning product in combination with avocado sugar (see application WO2005/115421), said composition being particularly suitable for the treatment of skin barrier repair and inflammation.
In some preferred embodiments of the invention, the Fuzhuan tea extract of the invention may be used as a skin conditioning product in combination with avocado peptides (see International application WO2005/105123), said composition being particularly suitable for the treatment of irritation and inflammation.
In some preferred embodiments of the present invention, the Fuzhuan tea extract of the present invention may be used as a skin conditioning product in a composition with avocado oil (see International applications WO2004/012496, WO2004/012752, WO2004/016106, WO 2007/057439).
In some preferred embodiments of the present invention, the extract of Fuzhuan tea of the present invention can be combined with(avocado furan, which can be obtained by the process described in international application WO 01/21605) the composition is used as a skin conditioning product. The compositions are particularly suitable for the treatment of inflammation, the promotion of scarring and for their anti-ageing properties.
In some preferred embodiments of the present invention, the fu tea extract of the present invention may be used as a skin conditioning product in combination with avocado or soy unsaponifiables. The avocado and soybean unsaponifiables that may be used in combination are preferably mixtures of avocado furan unsaponifiables and soybean unsaponifiables in a ratio of about 1:3 to 2:3, respectively.
In some preferred embodiments of the present invention, the fu tea extract of the present invention can be used as a skin conditioning product in a composition with lupeol (FR2822821, FR 2857596). The compositions are particularly suitable for supporting scarring.
In some preferred embodiments of the present invention, the extract of Fuzhuan tea of the present invention may be used in combination with lupin peptides as a skin conditioning product, such as lupin peptides obtained according to the method described in application WO 2005/102259. The compositions are particularly suitable for the treatment of inflammation and are used for their anti-aging properties.
In some preferred embodiments of the present invention, the extract of Fuzhuan tea of the present invention may be combined with a total lupin extract (see International application WO2005/102259) for use as a skin conditioning product, said composition being particularly suitable for treating irritation.
In some preferred embodiments of the present invention, the fu tea extract of the present invention may be used in combination with lupin oil as a skin conditioning product, preferably sweet white lupin oil, such as sweet white lupin oil described in international application WO 98/47479.
In some preferred embodiments of the present invention, the extract of Fuzhuan tea of the present invention may be combined with an extract of maca peptides (see International application WO2004/112742) for use as a skin conditioning product. Said compositions are particularly preferred for their cicatrizing and anti-ageing properties.
In some preferred embodiments of the present invention, the Fuzhuan tea extract of the present invention may be used as a skin conditioning product in combination with rice peptide (see International application 2008/009709). The compositions are particularly preferred for their properties associated with stimulating melanogenesis and with melanin transfer.
In some preferred embodiments of the present invention, the extract of Fuzhuan tea of the present invention can be combined with circulating ceramide(oxazoline derivatives) make up compositions useful as skin conditioning products, such as the cyclic ceramides described in International applications WO2004/050052, WO2004/050079 and WO 2004/112741. The compositions are particularly suitable for treating inflammatory reactions.
In some preferred embodiments of the present invention, the extract of fu tea of the present invention may be used in combination with an extract of quinoa as a skin conditioning product, in particular a peptide extract (see international application WO 2008/080974). The compositions are particularly suitable for the treatment of inflammatory diseases and skin barrier repair.
In some preferred embodiments of the present invention, the fu tea extract of the present invention may be used as a skin conditioning product in a composition with cupuacu butter (cupuacu butter). The compositions are particularly preferred for their wetting properties.
In some preferred embodiments of the present invention, the fu tea extract of the present invention may be used as a skin conditioning product in combination with rapeseed oil serum (rapeseed oleodesidate).
In some preferred embodiments of the present invention, the fu tea extract of the present invention may be used as a skin conditioning product in combination with corn oil serum (corn oleostillate).
All of these combinations, except the fu tea extract, comprise at least one other active compound, and may comprise two, three, four or more active compounds as described above.
In addition to these actives described above, alone or in combination with the actives mentioned above, the fu tea extract of the present invention may be used in combination with sunscreen actives known to those skilled in the art, such as UVB and/or UVA filters or shades or any inorganic and/or organic shades or filters, which will adjust their selection and their concentration according to the degree of protection sought.
As examples of sunscreen actives, mention may be made in particular of titanium dioxide, zinc oxide, methylenebis-benzotriazolyl tetramethylbutylphenol (brand name: TINOSORB M) and bis-ethylhexyloxyphenol methoxyphenyl triazine (brand name: TINOSORB S), octyl-salicylic acid, butylmethoxydibenzoylmethane, p-xylylene dicamphor sulfonic acid, 4-methylbenzylidene camphor, benzophenone, ethylhexyl methoxycinnamate, ethylhexyl dimethyl PABA and diethyl hexyl butamido triazone.
The fu tea extract of the present invention can be prepared with pharmaceutically or cosmetically, nutraceutically suitable carriers in a variety of formulations suitable for topical or oral administration.
According to a first variant, the various formulations are suitable for topical application and comprise creams, gels, emulsifiers, emulsions, balms, lotions, oils, aqueous or hydro-alcoholic or glycolic acid solutions, powders, patches, sprays or any other product for external application.
According to a second variation, a plurality of formulations are suitable for oral administration, wherein the fu tea extract may be included in a dietary supplement or a dietary composition.
In the context of the present invention, the dietary supplement may be provided in the form of hard or soft gelatin or vegetable capsules. The dietary supplement may thus comprise 10% to 100% by weight of fu tea extract.
Without limitation, the fu tea extract of the present invention may also be incorporated in dietary compositions such as foods, beverages, and nutraceuticals, including the following products:
1) dairy products such as cheese, butter, milk and other milk-like beverages, mixes and spreads containing milk products, ice cream and yogurt;
2) fat-based products such as margarines, spreads, mayonnaises, cooking fats, frying oils and vinaigrette;
3) cereal-based products consisting of cereals, such as bread and pasta products, whether or not these foods are cooked, baked or processed;
4) confections such as chocolate, confectionery, chewing gum, sweets, toppings (toppings), sorbet, cake coatings (icing) and other garnishes (garnishe);
5) alcoholic or nonalcoholic beverages, including soda water and other soft drinks, juices, dietary supplements, meal substitutes in the form of beverages, e.g. under the brand name BoostTMAnd EnsureTMThose meal substitutes sold, and;
6) various products such as eggs, processed foods such as soups, ready-to-use pasta sauces, prepared dishes and other products of the same type.
The fu tea extract can be incorporated into foods, nutraceuticals, dietary products, especially high protein products, or beverages directly and without further modification by means of techniques such as mixing, pouring, injecting, blending, adsorbing, kneading, and spraying.
The mode of administration and the dosing regimen and the optimal galenical form of the compounds and compositions of the invention can be determined on the basis of the criteria generally considered when establishing a pharmacotherapy, in particular a dermatological therapy, suitable for the patient, such as the age or weight of the patient, the severity of the overall condition of the patient, the tolerance to said therapy, the apparent side effects and the skin type.
The invention also relates to a method for the cosmetic treatment of acne, in particular the application of the cosmetic composition of the invention to the affected skin area.
The invention also relates to a method for the cosmetic treatment of acne by the oral route, in particular the oral administration of the nutraceutical composition of the invention to the affected individuals.
The invention also relates to the use of an extract of Fuzhuan tea for the preparation of a cosmetic, nutraceutical or dermatological composition for the treatment or prevention of acne.
In the context of cosmetic or dermatological use, the composition will preferably be formulated in a formulation suitable for topical application.
In the context of use in food, the composition will preferably be formulated in a formulation suitable for oral administration for nutritional or cosmetic purposes (beauty foods).
Preferably, the Fuzhuan tea extract also has specific effects of stimulating proliferation and maintaining the activity of stem cells, resisting aging and promoting healing. The Fuzhuan extract had the effect of increasing the expression of the ratio of ALDH positive cells, Ki67, on human epidermal stem cells as described in the examples below.
Preferably, the extract of Fuzhuan tea and the extract of Fuzhuan tea according to the present invention are intended to inhibit inflammation by specific action against Propionibacterium acnes. The fu tea extract specifically locks in the acne inflammatory process that plays a central role in lesion development and exacerbation. Thus, the examples presented below show that the fu tea extract has several effects on keratinocytes:
anti-inflammatory action: inhibiting inflammatory early mediators (IL-1 alpha, IL-1 beta) and late mediators (IL-8); inhibition of keratinocyte-induced MMPs (MMP-2 and MMP-9); inhibition of VEGF release.
The Fuzhuan tea extract also has the following effects on Propionibacterium acnes: inhibiting propionibacterium acnes from inducing IL-8; inhibiting Propionibacterium acnes induces MMP-9.
In some aspects of the invention, the invention also comprises the application of the Fuzhuan tea extract for maintaining and/or increasing the skin vitality and elasticity, reducing the skin injury, resisting aging and the like by local or oral administration. Such as maintenance/augmentation of skin cell type I collagen, resistance to light-induced skin damage and aging, etc., as described in the examples.
In another aspect of the present invention, the present invention also includes the use of said fu tea extract for topical or oral administration for enhancing hair follicles and reducing loss of skin appendages, preferably hair loss. For example, the examples describe maintaining and/or increasing collagen type V and/or fibrillin-1 expression and/or for increasing proliferation of skin fibroblasts, hair follicle fibroblasts and/or for increasing cell viability and/or ATP synthesis and/or mitochondrial activity and/or reducing cell damage and/or reducing cell senescence.
In one embodiment of the present invention, a cosmetic treatment method comprises topically applying the present fu tea extract or a composition comprising the same to all or part of the body selected from: legs, feet, axilla, hands, thighs, abdomen, neck line, neck, arms, torso, back, face, including skin appendages, preferably hair, and/or scalp, more advantageously scalp.
The term "aging" and the term "skin aging" in the context of the present invention are used to describe visible changes in the appearance of the skin and those detectable by touch, such as, for example, wrinkles, fine lines, roughness, expression lines, stretch marks, discontinuities, deep wrinkles, sagging of the skin (e.g., cheek sagging, under-eye puffiness, chin), increased pore size, loss of elasticity, loss of resiliency, loss of firmness, elastosis, abnormal differentiation, hyperkeratosis, keratosis, skin color changes (e.g., blotches, redness, or under-eye puffiness), formation of hyperpigmented regions (e.g., age spots, yellow spots, or freckles), loss of suppleness, cellulite skin, loss of collagen structure and formation of the stratum corneum, dermis, epidermis, vascular system (e.g., spider veins or telangiectasia), in a non-limiting sense, Or other histological changes of these tissues close to the skin. Skin aging is a process with two major components: chronological aging, which is attributed to the passage of time; and photo-induced aging, which is attributed to the level of exposure to ultraviolet radiation and is referred to as photo-aging. The sum of several environmental factors, such as exposure to tobacco smoke, exposure to pollution, and climatic conditions (e.g., cold and/or wind), also contribute to skin aging. In the context of the present invention, a "skin anti-aging treatment" is a treatment for preventing, delaying, and/or reducing aging of human skin.
Due to the adoption of the technical scheme, the invention has the following advantages and beneficial effects:
the fu tea extract of the present invention is intended to inhibit inflammation by a specific action against propionibacterium acnes, and has several actions against keratinocytes: the Fuzhuan tea extract achieves the pharmaceutical function of resisting acne by inhibiting the gene expression of inflammatory mediators or matrix protease in keratinocytes and inhibiting the synthesis and release of VEGF in the keratinocytes; the anti-aging function is realized by promoting the expression of cell collagen, increasing the synthesis of cell fibrillin, maintaining the dryness of stem cells and stimulating the proliferation of stem cells; the dermatological use of hair follicle enhancement and anti-hair loss is achieved by promoting ATP synthesis or enhancing mitochondrial metabolic activity in hair follicle papilla fibroblasts, increasing cell viability of hair microfollicles or reducing microfollicle membrane damage; the skin care product can prevent skin problems caused by Asian dust by removing and eliminating toxins, increasing the expression of the skin antimicrobial peptide hBD3 and inhibiting the generation of active oxygen, and provides a new path for skin care such as anti-aging skin care, acne resistance, alopecia prevention, dust influence prevention and the like.
Detailed Description
In order to more clearly illustrate the invention, the invention is further described below in connection with preferred embodiments. It is to be understood by persons skilled in the art that the following detailed description is illustrative and not restrictive, and is not to be taken as limiting the scope of the invention.
Example 1
The preparation method of the Fuzhuan tea extract comprises the following steps:
grinding Fuzhuan tea into powder with diameter not more than 0.5cm, completely crushing the Fuzhuan tea powder with a dry wall breaking machine, adding water vapor for pre-soaking until the water content is increased to 40%, putting the pre-soaked Fuzhuan tea powder into an extraction tank, and continuously extractingFeeding CO into the tank2And the crude extract is gradually extracted. CO with crude extract2Sending to a cleaning tank, allowing the Fuzhuan tea extract to enter water phase, and passing through supercritical CO2Extracting to obtain crude extract, hydrolyzing starch and fiber (cellulose, hemicellulose, etc.) with mixture of cellulase and alpha-amylase (concentration of 0.5% each), heating at 65 deg.C for 30 min to denature the enzyme, and centrifuging to remove impurities; removing residual protein (collecting exudate) with 15kDa ultrafiltration column, bleaching extract with activated carbon and filtering and recovering, sterilizing the product with 0.2 μm filter membrane, and lyophilizing or packaging to obtain Fuzhuan tea supercritical CO2And (3) extracting.
The Pu' er tea extract is prepared according to the same method and is used as a reference substance of subsequent experiments.
Example 2
Fuzhuan tea extract for enhancing type I collagen
The fuzhuan tea extract prepared in example 1 was added to a culture solution (DMEM culture solution) of human skin fibroblasts (ATCC) (final concentration of the fuzhuan tea extract in the culture solution was 0.5% by mass to volume), to confirm that the fuzhuan tea extract promotes type I collagen synthesis at a cellular level.
The collagen was measured by using PICP kit (procollagen type I C peptidase immunoassay kit, R)&D Systems) were used. Human skin fibroblasts were cultured in DMEM at 2X 105The individual cells/well were aliquoted into 6-well plates. After cell adhesion was confirmed, the fu tea extract as an active ingredient was dissolved in a culture solution (the final concentration of the fu tea extract in the culture solution was 0.5% by mass/volume) to prepare a treatment group, the pu' er tea extract at the same concentration was prepared as a control group, and the culture solution was used alone in the blank group. At 37 deg.C, 5% CO2The cells are cultured in an incubator under the conditions for 24 hours, the content of the type I collagen in the cell lysate is measured, the results are shown in table 1, and the results show that the poria cocos tea extract can effectively promote the expression of the collagen.
TABLE 1 collagen concentration
Treatment group | Control group | Blank group | |
Type I collagen concentration [ mu ] g/ml | 0.030 | 0.002 | 0.002 |
Increase ratio (%) | 1500 | - | - |
Example 3
Effect of Fuzhuan tea extract on skin model
This example was performed using the fu tea extract prepared in example 1.
Skin aging test by ultraviolet irradiation was carried out on the skin, and the collagen fiber network at the epidermal-dermal junction in the skin was damaged by ultraviolet irradiation. Thus, the amount and morphology of collagen fibrils serves as an indicator of skin aging.
The fu tea extract prepared in example 1 was dissolved in DMEM medium to give a final concentration of 0.5% by mass/volume as a treatment group; pu' er tea extract of the same concentration was used as a control group, and the same DMEM medium without any tea extract was used as a blank group. Before each irradiationThe skin surface of hairless mice was coated with 100. mu.l of Fuzhuan tea extract, and the ultraviolet irradiation test was carried out after 30 minutes. The method of ultraviolet irradiation is as follows: two 40W long-wave ultraviolet lamps and two 40W medium-wave ultraviolet lamps (from Philips, 320-400nm for long wave and 320-320 nm for medium wave) are adopted, and the distance between the lamps and the skin is 35 cm. Irradiation was carried out for 2 hours per day for 6 weeks. Detecting with ultraviolet intensity tester (photoelectric instrument factory of Beijing university of teachers and universities), and accumulating irradiation intensity to long wave 165J/cm2Medium wave ultraviolet 4.667J/cm2. The animals were sacrificed at 6 weeks, the skin tissue of hairless mice receiving uv irradiation was stained by Masson's Trichrome, the stained area was observed by an optical microscope, the stained area of the control group was taken as a standard area of 100%, and the results of the stained area of the treatment group and the stained area of the control group are shown in table 2, and it can be seen from table 2 that the fu tea extract, i.e., the treated group, can significantly enhance the network area of collagen fibers compared to the control group, suggesting that the fu tea extract can be used for preparing anti-photoaging products.
TABLE 2
Mean value of | SD | p value | |
Blank group | 100 | 4.5 | |
Control group | 102.61 | 7.11 | p>0.05 |
Treatment group | 164.51 | 14.7 | p<0.05 |
Artificial skin (EpiDermFT from Mattek, Ashland, USA)TM) Stabilization was carried out in a special medium (EFT-400) for 18 hours. As a treatment group, 100 μ l of the fu tea extract prepared in example 1 was coated on the surface of artificial skin at a concentration of 0.5% (mass to volume, DMEM medium) as an effective ingredient; pu' er tea extract with the same concentration is used as a control group, and a blank DMEM culture medium is used as a blank group. After 30 minutes, the artificial skin was irradiated by a 40W medium-wave ultraviolet light source (from Philips) at a position 10cm below the source (irradiation time: 5min, cumulative dose: 30 mJ/cm)2) Then, conventional cultivation is performed. After 24 hours, the artificial skin tissue was fixed with 10% formaldehyde and embedded in paraffin, by Masson's Trichrome: M&T) and cut into 5 μm tissues, thereby observing and calculating the dyeing area of collagen fibers (collagen fibers), the results are shown in table 3, and the results show that the fu tea extract prepared in example 1 has an anti-aging effect under light conditions.
TABLE 3
Mean value of | SD | p value | |
Blank group | 100 | 7.92 | |
Control group | 96.51 | 5.55 | p>0.05 |
Treatment group | 144.51 | 12.73 | p<0.05 |
Example 4
The effect experiment of preventing and treating acne was carried out on the fu tea extract prepared in example 1.
A keratinocyte monolayer model; research on expression of L-1 alpha, IL-1 beta, IL-8, MMP-2 and MMP-9, keratinocyte/Propionibacterium acnes co-culture model; study of MMP-9 expression, keratinocyte monolayer model; study of the effects of IL-1 α and VEGF, keratinocyte/Propionibacterium acnes co-culture model; model building, experimental methods, real-time RT-PCR methods and results calculation for the study of the effects of IL-8 production reference (CN 102481245B). The results are as follows:
fu tea extract for initial inflammatory mediators: effects of IL-1 α and IL-1 β genes encoding IL-1 α and IL-1 β were analyzed for expression.
After 48 hours of treatment, 0.5% and 1% fu tea extract were tested to significantly inhibit IL-1 α gene expression (as shown in table 4) and IL-1 β gene expression (as shown in table 5) in keratinocytes, with 1% pu' er tea extract as a control and the blank containing only culture medium.
Table 4: IL-1 alpha gene expression in keratinocytes
IL-1 alpha assay | RQ | Inhibition% | p value |
Blank space | 1 | ||
1% Pu' er tea extract | 0.95 | -5 | p>0.05 |
0.5% Fuzhuan tea extract | 0.32 | -68 | p<0.05 |
1% Fuzhuan tea extract | 0.15 | -85 | p<0.05 |
Table 5: IL-1 beta gene expression in keratinocytes
The results in tables 4 and 5 show that the Fuzhuan tea extract can effectively inhibit the expression of IL-1 alpha and IL-1 beta of keratinocytes and effectively resist inflammation.
Effect of fu tea extract on IL-8 expression: secondary inflammatory mediators
1. Analysis of expression of genes encoding IL-8
After 48 hours of treatment, 0.5% and 1% fu tea extract were tested to significantly inhibit IL-8 gene expression in keratinocytes (as shown in table 6).
Table 6: IL-8 gene expression in keratinocytes
IL-8 assay | RQ | Inhibition% | p value |
Blank space | 1 | ||
1% Pu' er tea extract | 0.96 | 4 | p>0.05 |
0.5% Fuzhuan tea extract | 0.21 | -79 | p<0.05 |
1% Fuzhuan tea extract | 0.12 | -88 | p<0.05 |
As can be seen from the data in Table 6, the Fuzhuan tea extract can inhibit the expression of IL-8 gene in keratinocytes, and effectively inhibit the generation of inflammation.
2. Effects on IL-8 production in keratinocytes stimulated by Propionibacterium acnes.
Treatment of keratinocytes with a Propionibacterium acnes suspension strongly stimulated IL-8 release, a secondary marker of inflammation (as shown in Table 7). Pretreatment with the Fuzhuan extract for 60 minutes inhibited IL-8 release by keratinocytes, with inhibition of IL-8 production beginning at 0.5% and reaching completion at 5%.
Table 7: analysis of IL-8 in keratinocyte/Propionibacterium acnes cocultures
As can be seen from the data in Table 7, the Fuzhuan tea extract can effectively reduce the release of IL-8 mediated by Propionibacterium acnes, and has the effect of remarkably inhibiting inflammation mediated by the Propionibacterium acnes.
Effect of Fuzhuan tea extract on matriptase MMP-2 and MMP-9
Analysis of MMP-2 expression
Treatment of keratinocytes with 0.5% fu tea extract for 48 hours resulted in significant inhibition (-75% inhibition) of MMP-2 gene expression (as shown in table 8).
Table 8: MMP-2 gene expression in keratinocytes
MMP-2 | RQ | Inhibition% | p value |
Blank space | 1 | ||
0.5% Pu her tea extract | 1.05 | p>0.05 | |
0.5% Fuzhuan tea extract | 0.255 | -75 | p<0.01 |
As can be seen from the data in Table 8, the Fuzhuan tea extract can effectively reduce the gene expression of keratinocyte MMP-2 and has the effect of remarkably inhibiting inflammation diffusion.
Analysis of MMP-9 expression
Among the matrix proteases involved in the pathology of acne, MMP-9 plays a particularly important role. In fact, this protease is up-regulated by proinflammatory cytokines, and also by propionibacterium acnes.
As shown in Table 9, analysis of the Q-PCR results showed: MMP-9 gene expression was inhibited in keratinocytes after 48 hours of treatment with the fu tea extract (at 0.5% -45% inhibition and at 1% -69% inhibition).
Table 9: MMP-9 gene expression in keratinocytes
MMP-9 | RQ | Inhibition% | p value |
Blank space | 1 | ||
1% Pu' er tea extract | 1.05 | p>0.05 | |
0.5% Fuzhuan tea extract | 0.55 | -45 | p<0.01 |
1% Fuzhuan tea extract | 0.31 | -69 | p<0.01 |
As can be seen from the data in Table 9, the Fuzhuan tea extract can effectively reduce the gene expression of keratinocyte MMP-9, and has the effect of remarkably inhibiting inflammation diffusion.
Similarly, modulation of MMP-9 expression was also assessed in a keratinocyte/Propionibacterium acnes co-culture model (as shown in Table 10). Using this model, the stimulatory effect of Propionibacterium acnes bacterial suspension on MMP-9 gene expression (+ 55%) was demonstrated. In contrast, pretreatment of keratinocytes with fu tea extract resisted and also inhibited this stimulatory effect against propionibacterium acnes (51% and 67% relative to keratinocytes treated with bacterial suspension).
Table 10: MMP-9 gene expression in keratinocyte/Propionibacterium acnes coculture
As can be seen from the data in Table 10, the Fuzhuan tea extract can effectively reduce the gene expression of MMP-9 mediated by Propionibacterium acnes, and has the effect of remarkably inhibiting inflammation mediated by Propionibacterium acnes.
Effect of Fuzhuan tea extract on angiogenesis (VEGF)
The potential inhibitory effect of the fu tea extract on the synthesis and release of VEGF by keratinocytes was studied and the results are presented in table 11. PMA stimulation of keratinocytes for 24 hours induced a large and significant release of VEGF (+ 266%). In contrast, pretreatment of keratinocytes with fu tea extract for 24 hours was on this effect and significantly inhibited this effect.
Table 11: analysis of VEGF in keratinocytes
As can be seen from the data in table 11, the fu tea extract can effectively reduce the secretion of VEGF, and has the effect of significantly inhibiting local vascular inflammation.
Example 5
Example 1 Fuzhuan tea extract prepared enhances collagen V expression in hair follicle fibroblasts
Normal human fibroblasts were cultured in FGM medium (Lonza) supplemented with Fuzhuan tea extract at final concentration of 0.5% and 1% by mass/volume for 48 hours at 37 deg.C under 5% CO2And then the cell culture medium is removed. The FGM medium of Pu' er tea extract at a mass-to-volume ratio of 1% was used as a control, and the same FGM medium without any tea extract was used as a blank control. The cell layer was lysed with ammonium hydroxide lysate (manufactured by MIBio corporation) at 4 ℃ for 10 minutes, and then collagen type V was measured with an anti-collagen V antibody diluted to 1/4000 in a buffer solution (PBS). After 60 minutes, the secondary antibody diluted to 1/25000 was applied for 60 minutes. After washing, ECL revealing solution (manufactured by seimerfin) was added and the fluorescence was measured (ENVision, PerkinElmer). The fluorescence results were normalized to the fluorescence obtained in the control medium (control) and compared to the fluorescence obtained in each conditionThe results obtained for the correlation of the amounts of collagen obtained were the average (n: 3) (SD: standard deviation) of 3 measurements, and the results are shown in table 12.
TABLE 12 Hair follicle fibroblast type V collagen expression
And (4) conclusion: in the analyzed hair follicle-derived fibroblasts, the Fuzhuan extract increases the collagen V expression by at least 34% and 104%, and shows that the Fuzhuan extract can remarkably enhance the property of the collagen expression, and can be used in medicines, cosmetics and nutraceuticals for enhancing hair follicles and reducing alopecia.
Example 6
Fuzhuan tea extract for increasing synthesis of fibrillin-1
Culturing normal human fibroblast cells in FGM medium (Lonza) at 37 deg.C under 5% CO for 48 hr2. The fu tea extract prepared in example 1 as an active ingredient was dissolved in the culture solution (final concentration of fu tea extract in the culture solution was 0.5% and 1% by mass/volume as a treatment group, 1% by mass/volume of pu' er tea extract as a control group, and the blank group had only the culture solution). At 37 deg.C, 5% CO2The culture was continued in the incubator under the conditions for 48 hours, and fibroblasts were collected and then lysed with a lysis buffer (produced by Biyuntian Co.) at 4 ℃ for 30 minutes to perform immunoblotting (Western Blots), and the protein concentration was measured by the BCA method. All samples were normalized to the total amount of Protein (n ═ 3), and quantitative studies were performed using a chemiluminescent substrate using an anti-fibrillin-1 antibody (LS-BIO) and a secondary antibody that was a peroxidase-conjugated antibody (Protein Simple), with the results shown in table 13.
TABLE 13 fibrillin-1 expression
Group of | Mean value of | SD | p value |
Blank [ Medium Only ]] | 100 | 6 | |
Pu' er tea extract 1% (w/v culture medium) | 102.5 | 11.1 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 165.6 | 15.5 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 205.4 | 25.2 | p<0.05 |
And (4) conclusion: the fu tea extract prepared in example 1 of the present invention showed increased synthesis of fibrillin-1 in fibroblasts compared to the control.
Example 7
Fuzhuan tea extract for promoting ATP synthesis increase in hair follicle papilla fibroblasts
Non-pathological human fibroblasts from hair follicle papilla were cultured in DMEM medium for 24 hours, and then the fu tea extract prepared in example 1 as an effective ingredient was dissolved in the culture solution (final concentration of fu tea extract in the culture solution was 0.5% and 1% by mass/volume ratio as a treatment group, 1% by mass/volume ratio of pu' er tea extract as a control group, and the blank group had only the culture solution). At 37 deg.C, 5% CO2The cultivation is continued for 6 days in the incubator with the condition, and the final concentration of the Fuzhuan tea extract is 0.5 percent and 1 percent by mass-volume ratio. ATP levels were measured by enzymatic methods (luciferin/luciferase complex; ATP Bioluminescence kit Roche Diagnostics) after 6 days (as shown in Table 14).
TABLE 14 ATP content
And (4) conclusion: the fu tea extract showed increased ATP synthesis compared to the control, confirming its use for enhancing the activity of hair follicles.
Example 8
Example 1 Fuzhuan tea extract prepared to enhance mitochondrial metabolic activity of hair follicle papilla fibroblasts
Culturing non-pathological human fibroblast of hair follicle papilla in DMEM medium at 37 deg.C and 5% CO for 24 hr2. The fu tea extract prepared in example 1 as an active ingredient was dissolved in the culture solution (final concentration of fu tea extract in the culture solution was 0.5% and 1% by mass/volume as a treatment group, 1% by mass/volume of pu' er tea extract as a control group, and the blank group had only the culture solution). At 37 deg.C, 5% CO2The culture was continued for 6 days in the conditioned incubator. By MTT (3- [4, 5-dimethylthiazol-2-yl) in the presence of succinic dehydrogenase]-2, 5-diphenyltetrazolium bromide) was measured for mitochondrial activity of fibroblasts. The resulting precipitate was extracted with DMSO, and the optical density of the DMSO solution was measured at 540nm (as shown in table 15).
TABLE 15 relative mitochondrial Activity
Mean value of | SD | p value | |
Blank [ Medium Only ]] | 100 | 14.3 | |
Pu' er tea extract 1% (w/v culture medium) | 91.3 | 11.3 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 138.4 | 20.5 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 176.5 | 25.5 | p<0.05 |
And (4) conclusion: the fu tea extract prepared in example 1 of the present invention showed an increase in mitochondrial activity of hair follicle papilla fibroblasts, which is involved in the enhancement of hair follicles, compared to the control.
Example 9
Example 1 Effect of Fuzhuan tea extract on micro hair follicles
The method for reconstructing the Fuzhuan tea extract comprises the following steps: the micro-follicle model involves co-culturing papillary fibroblasts, keratinocytes from the outer sheath of the hair follicle, and melanocytes in three dimensions, which constitute a reconstructed organ model closest to the hair follicle due to the ability to integrate the neuro-epidermal-mesenchymal interactions between the various cell types.
Non-pathological papilla fibroblasts were cultured in DMEM medium for 3 days to form monolayer epidermal papilla. Then, melanocytes and keratinocytes of the outer skin of hair follicles were added to the above-mentioned single-layered epidermal papilla to form micro hair follicles; after 24 hours of culture, the Fuzhuan tea extract prepared in example 1 as an effective component was dissolved in a culture solution (the final concentration of the Fuzhuan tea extract in the culture solution is 0.5% by mass/volume as a treatment group, the Pu' er tea extract in the final concentration of 0.5% by mass/volume as a control group, and the blank group is only the culture solution.) at 37 ℃ and 5% CO2The incubation was continued in the conditioned incubator for 48 hours. The treatment was carried out for 48 hours, and the medium and the microcapillaries were sampled for analysis.
The viability of the microcapillaries was measured by the PrestoBlue method (Thermo Fisher Scientific) and determined 48 hours after treatment, with the values in table 16 expressed as the mean% of the controls normalized.
TABLE 16 relative cell viability
Mean value of | SD | p value | |
Blank [ Medium Only ]] | 100 | 9.5 | |
Pu' er tea extract 0.5% (w/v culture medium) | 97.2 | 3.3 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 164.5 | 21.5 | p<0.05 |
And (4) conclusion: the fu tea extract prepared in the embodiment 1 of the invention has the capability of increasing the cell viability of the micro hair follicle, so that the fu tea extract has activity on enhancing hair follicle, and therefore, the fu tea extract can be used for preparing the medicine or the cosmetic for preventing alopecia.
Assessment of reduction of Membrane Damage at the level of micro Hair follicles
Measuring cell damage by colorimetry using lactate dehydrogenase assay, enablingCell damage can be quantified based on the measurement of lactate dehydrogenase activity in damaged cells in the culture medium. The increase in cell membrane damage and cell lysis leads to an increase in lactate dehydrogenase activity, which is proportional to the number of lysed cells. Non-pathological papilla fibroblasts were cultured in DMEM medium for 3 days to form monolayer epidermal papilla. Then, melanocytes and keratinocytes of the outer skin of hair follicles are added to the above-mentioned single-layer epidermal papilla to form micro hair follicles; after 24 hours of culture, the Fuzhuan tea extract prepared in example 1 as an effective component was dissolved in a culture solution (the final concentration of the Fuzhuan tea extract in the culture solution is 0.5% by mass and volume as a treatment group, 0.5% by mass and volume of Pu' er tea extract as a control group, and the blank group is only the culture solution.) at 37 ℃ and 5% CO2The incubation was continued for 48 hours in the incubator under the conditions, and then the lactate dehydrogenase activity in the medium was measured using a lactate dehydrogenase release assay kit (produced in Biyun sky) (as shown in Table 17).
TABLE 17 relative cellular injury
Mean value of | SD | p value | |
Blank [ Medium Only ]] | 100 | 12.5 | |
Pu' er tea extract 0.5% (w/v culture medium) | 93 | 6.1 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 35 | 10.5 | p<0.05 |
And (4) conclusion: the fu tea extract prepared in the embodiment 1 of the invention has the capability of relieving cell membrane damage, so that the fu tea extract has activity on strengthening hair follicles, and strengthening hair follicles and promoting the reduction of alopecia, namely, the fu tea extract prepared in the embodiment 1 of the invention can be used as a medicine or a cosmetic for preventing alopecia.
Example 10 Fuzhuan tea extract maintains Stem cell desiccating and proliferative Activity
This example was performed using the fu tea extract prepared in example 1.
Human epidermal stem cells (ESC, ATCC) at 2X 105The individual cells/well were aliquoted into 6-well plates in DMEM medium. After confirming cell adhesion, the fu tea extract prepared in example 1 as an active ingredient was dissolved in a culture medium (final concentration of fu tea extract in the culture medium was 0.5% by mass/volume as a treatment group, 0.5% by mass/volume of pu' er tea extract as a control group, and only culture medium was used in a blank group) at 37 ℃ with 5% CO2The incubation was continued for 24 hours in the conditioned incubator. Flow cytometry was used to determine the ALDH-and Ki 67-positivity of ESC cells, and the results are shown in Table 18.
TABLE 18 ALDH positivity and Ki67 positivity
Treatment group | Control group | Blank group | p-value (treatment vs. control) | |
ALDH positive rate | 58.5% | 29.1% | 26.7% | p<0.05 |
Ki67 positive rate | 45.5% | 15.5% | 18.3% | p<0.05 |
The results show that the Fuzhuan tea extract has very strong effects of maintaining dryness of the epidermal stem cells and stimulating the proliferation of the epidermal stem cells.
Example 11
The Fuzhuan tea extract prepared in example 1 copes with active oxygen production in human keratinocytes caused by Asian dust
Asian dust is a climatic phenomenon originating in deserts of China, Mongolia, China, Russia and the like. In these places, sand or yellow sand dust blows east with the wind and falls to the ground. In the north, such as Beijing, is affected by Asian dust almost every year. Asian dust contains organic and inorganic substances, and its physical properties and composition are different, even containing metals that may have biological effects. Large particles contained in Asian dust remain in place or around it, while particles having a diameter of 10 μm or less (particulate matter 10; PM10), and PM2.5, which has been a continuous outbreak in recent years, is also a part of this type of climate pollution.
It has been reported that the particles, when inhaled, can reach deep into the gas exchange region of the sub-segmental bronchi and lungs and may damage the respiratory system (Yanagisawa et al, Exp Biol Med 232: 1109-. A number of reports have been made of the health effects of asian dust on human respiratory disease. In experimental studies in mice, an increased oxidative stress-related index was found in the lungs of mice perfused with Asian dust (Naota et al, Toxicol Pathol.2010 Sep30. clinically, if the skin is directly exposed to Asian dust, it may cause contact dermatitis by allergic reactions. furthermore, dry and intense Asian dust storms are known to cause dry skin, keratinization, itching, acne, atopy by depriving the skin of moisture.
Culturing human epidermal new keratinocyte cells for 24 hr in DMEM at 37 deg.C and 5% CO2. The Fuzhuan tea extract prepared in example 1 as an effective component was dissolved in a culture solution (final concentration of the Fuzhuan tea extract in the culture solution was 0.5% and 1% by mass/volume as a treatment group, 1% by mass/volume of Pu' er tea extract was used as a control group, and only the culture solution was used in a blank group), and then 30. mu.g/mL Asian dust samples were added respectively, and 5% CO was added at 37 ℃2The incubation was continued for 24 hours in the incubator under the conditions. Asian dust samples were collected during the asian dust season on the balcony roof of a national trade third generation a building (beijing city). Human epidermal neonatal keratinocytes were washed twice with 10mL Phosphate Buffered Saline (PBS) and 1 min after addition of 1mM luminol and 20 units/mL horseradish peroxidase (HRP) using a Glomax20/20 luminometerChemiluminescence was measured in 2mL PBS and the results are shown in table 19.
TABLE 19 relative active oxygen levels
The results show that the Fuzhuan tea extract prepared in example 1 of the present invention can inhibit the generation of active oxygen in normal human keratinocytes mediated by Asian dust.
Example 12
Fuzhuan tea extract prepared in example 1 has effects of toxin detoxification and elimination factor and antimicrobial peptide expression
In the same manner as in example 11, human epidermal neonatal keratinocyte cells were cultured in DMEM medium at 37 ℃ and 5% CO for 24 hours2. The Fuzhuan tea extract prepared in example 1 as an effective component was dissolved in a culture solution (final concentration of the Fuzhuan tea extract in the culture solution was 0.5% and 1% by mass/volume as a treatment group, 1% by mass/volume of Pu' er tea extract was a control group, and a blank group had only the culture solution), and then 30. mu.g/mL Asian dust samples were added respectively, and 5% CO was added at 37 ℃2The incubation was continued for 24 hours in the conditioned incubator. Asian dust samples were collected during the asian dust season on the balcony roof of a state trade third generation a building (beijing city). Experiment each group of cells was washed twice with 10mL of phosphate buffer and total rna (total rna) was isolated from the cells using trizol (invitrogen). The isolated RNA was again purified using the RNA kit (Qiagen) and the quality of the RNA was analyzed using the Bioanalyzer2100 (Agilent). cDNA was synthesized from the isolated RNA using Superscript Reverse Transcriptase (RT) II kit, and quantitative analysis of the cDNA was performed by real-time reverse transcriptase polymerase chain reaction (qPCR). Use ofThe TaqMan gene expression assay kit (TaqMan gene expression assay kit, Applied Biosystems) detects the expression levels of GSTT1(Hs00184475_ m1), NQO1(Hs01045994_ m1) and hBD3(Hs00218678_ m1), and the results are shown in tables 20 to 22.
TABLE 20 NQO1 relative expression levels
Average (%) | SD | p value | |
No Asian dust was added | 140.56 | 18.56 | |
Blank control | 100 | 11.27 | |
Pu' er tea extract 1% (w/v culture medium) | 106.12 | 8.67 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 266.36 | 30.15 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 487.36 | 45.22 | p<0.05 |
TABLE 21 GSTT1 relative expression levels
TABLE 22 hBD3 relative expression levels
Average (%) | SD | p value | |
No Asian dust was added | 256.75 | 30.11 | |
Blank control | 100.00 | 12.33 | |
Pu' er tea extract 1% (w/v culture medium) | 93.35 | 10.17 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 197.69 | 15.98 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 499.26 | 50.76 | p<0.05 |
The results show that the Fuzhuan tea extract prepared in example 1 of the invention can increase the expression of the detoxin protein NQO1, the skin antimicrobial peptide hBD3 of natural immune factors and the GSTT1 of toxin-removing enzyme in normal human keratinocytes.
Example 13
Example 1 Fuzhuan tea extract prepared in example 1 has effect on anti-oxidized protein gene expression
In the same manner as in example 11, human epidermal neonatal keratinocyte cells were cultured in DMEM medium at 37 ℃ and 5% CO for 24 hours2. The fu tea extract prepared in example 1 as an active ingredient was dissolved in a culture solution (final concentration of fu tea extract in the culture solution)The mass ratio of the extract to the extract was 0.5% and 1% by volume, the mass ratio of the extract to the extract. ) Then, 30. mu.g/mL Asian dust samples were added separately at 37 ℃ with 5% CO2The incubation was continued for 24 hours in the conditioned incubator. Asian dust samples were collected during the asian dust season on the balcony roof of a state trade third generation a building (beijing city). Experiment each group of cells was washed twice with 10mL of phosphate buffer and total rna (total rna) was isolated from the cells using trizol (invitrogen). The isolated RNA was again purified using the RNA kit (Qiagen) and the quality of the RNA was analyzed using the Bioanalyzer2100 (Agilent). cDNA was synthesized from the isolated RNA using Superscript Reverse Transcriptase (RT) II kit, and quantitative analysis of the cDNA was performed by real-time reverse transcriptase polymerase chain reaction (qPCR). The results of measuring the expression levels of GPX1(Hs00829989_ gH), catalase (Hs 0015638 _ m1), TRX1(Hs01555212_ g1) and PRDX1(Hs00602020_ mH) using TaqMan gene expression assay kit (TaqMan gene expression assay kit, A pplied Biosystems) are shown in tables 23 to 26.
TABLE 23 relative expression levels of GPX1
Average (%) | SD | p value | |
No Asian dust was added | 165.66 | 18.66 | |
Blank control | 100.00 | 7.15 | |
Pu' er tea extract 1% (w/v culture medium) | 109.12 | 6.18 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 198.22 | 210.35 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 455.33 | 50.62 | p<0.05 |
TABLE 24 relative catalase expression levels
Average (%) | SD | p value | |
No Asian dust was added | 256.56 | 30.11 | |
Blank control | 100.00 | 16.67 | |
Pu' er tea extract 1% (w/v culture medium) | 93.31 | 10.81 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 194.13 | 20.74 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 398.44 | 41.94 | p<0.05 |
TABLE 25 TRX1 relative expression levels
Average (%) | SD | p value | |
No Asian dust was added | 164.18 | 19.65 | |
Blank control | 100.00 | 18.66 | |
Pu' er tea extract 1% (w/v culture medium) | 115.91 | 8.94 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 208.81 | 22.84 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 299.32 | 35.31 | p<0.05 |
TABLE 26 relative expression levels of PRDX1
Average (%) | SD | p value | |
No Asian dust was added | 301.57 | 32.66 | |
Blank control | 100.00 | 9.91 | |
Pu' er tea extract 1% (w/v culture medium) | 123.31 | 5.57 | p>0.05 |
Fuzhuan tea extract 0.5% (w/v culture medium) | 291.54 | 18.85 | p<0.05 |
Fuzhuan tea extract 1% (w/v culture medium) | 466.69 | 50.02 | p<0.05 |
The results show that the Fuzhuan tea extract prepared in example 1 of the invention can increase the relative expression levels of antioxidant enzymes GPX1, catalase, TRX1 and PRDX1 for scavenging active oxygen, and can effectively resist Asian dust mediated oxidative stress reaction.
Example 14
Example 1 anti-aging skin care assay of Fuzhuan tea extract
According to the mass percentage, 4% of the Fuzhuan tea extract prepared in the embodiment 1 of the invention, 5% of butanediol, 0.2% of nipagin ester and 90.8% of water are respectively weighed, and the raw material components are mixed to obtain the anti-aging skin lotion.
The prepared anti-aging skin care lotion is further detected, and the result is as follows: the anti-aging skin care lotion is a brownish red transparent solution, has fragrant and pleasant smell, and has very fresh and cool feeling and good skin feeling after being sprayed on the surface of the skin.
After the anti-aging skin lotion is stored for 3 years on a shelf at normal temperature, the anti-aging skin lotion does not deteriorate, and all sensory indexes, physical and chemical indexes and sanitary indexes of the product meet the corresponding national standards; the prepared anti-aging skin lotion is subjected to a heat resistance test for 24 hours at the temperature of 40 +/-1 ℃, then the skin lotion is recovered to the room temperature, the test shows that the skin lotion is not turbid after the skin lotion is recovered to the room temperature, and all sensory indexes, physical and chemical indexes and sanitary indexes of the skin lotion after the skin lotion is recovered to the room temperature meet the corresponding national standards. The prepared anti-aging skin care water is subjected to a cold resistance test for 24 hours at the temperature of minus 15 +/-1 ℃, then the skin care water is recovered to the room temperature, the detection shows that the skin care water is not turbid after the skin care water is recovered to the room temperature, and all sensory indexes, physical and chemical indexes and sanitary indexes of the skin care water after the skin care water is recovered to the room temperature meet the corresponding national standards.
24 volunteers were selected and randomized for gender. The anti-aging skin lotion prepared in the example was randomly applied to one of the left cheek and the right cheek and one of the left corner and the right corner of the eye of each volunteer, respectively, and used as an experimental group; one cheek and canthus of volunteers who did not use the anti-aging skin lotion prepared according to the present invention were used as a control group.
The volunteers respectively apply the anti-aging skin lotion prepared by the embodiment once in the morning and at night every day, the service cycle is 6 weeks, and other cosmetics cannot be used in the test cycle. Then, the anti-aging skin lotion prepared in this example was comparatively analyzed for the improvement of skin elasticity and wrinkles of volunteers using a skin elasticity tester (Bareiss) and a facial wrinkle imager (Visia), and the results are shown in table 27:
watch 27
Detecting items | Anti-aging skin care lotion |
Wrinkle (wrinkle) | Compared with the control group, the wrinkle depth of the experimental group becomes shallow, and the effect is very obvious |
Elasticity of skin | Compared with the control group, the skin elasticity of the experimental group is obviously improved |
The result shows that the anti-aging skin lotion prepared by the embodiment obviously has the effects of resisting wrinkles and enhancing skin elasticity.
Example 15
Anti-aging skin care lotion prepared from Fuzhuan tea extract prepared in example 1
According to the mass percentage, the camellia sinensis extract is 3% of the poria cocos tea extract prepared in the embodiment 1 of the invention, wherein the caprylic/capric triglyceride is 10%, the white oil is 5%, the stearyl alcohol is 2%, the glycerin is 3%, the xanthan gum is 0.5%, the sorbitan stearate is 2.5%, the sucrose cocoate is 2.5%, the citric acid monohydrate is 1%, the paraben is 0.5%, the citronellol is 0.1%, and the water is 69.9%. Respectively weighing the raw materials of the components, and then preparing the anti-aging skin care emulsion according to the following steps:
1) adding xanthan gum, glycerol, sorbitan stearate and sucrose cocoate into a water phase pot, uniformly stirring, and heating to 80-85 ℃ to obtain a water phase;
2) adding caprylic/capric triglyceride, white oil and stearyl alcohol into an oil phase pretreatment pot, mixing, stirring, and heating to 80-85 deg.C to obtain oil phase;
3) and (4) completely sucking the oil phase into a vacuum emulsifying kettle through filtration, and starting a scraper blade to stir. Then filtering and sucking water phase, after finishing the water phase, sequentially starting rapid stirring and vacuum emulsification, after finishing the emulsification, keeping the temperature and stirring for a few minutes, and then starting cooling water to cool and stir;
4) when the temperature is reduced to about 45 ℃, adding citric acid monohydrate and water, fully and uniformly stirring, and adjusting the pH value of a mixed system to be neutral;
5) sequentially adding nipagin ester, the Fuzhuan tea extract prepared in the embodiment 1 of the invention and citronellol into a mixed system, vacuumizing again, starting a scraper, stirring uniformly, and continuously cooling to below 38 ℃ with cooling water;
6) stopping cooling water, breaking vacuum, carrying out physical and chemical index inspection on the mixed system, filtering and discharging after the mixed system is qualified, and obtaining the anti-aging skin care emulsion.
30 volunteers were selected and randomized for gender. The anti-aging skin care lotion prepared in the example was randomly applied to one of the left cheek or the right cheek and one of the left corner of the eye and the right corner of the eye of each volunteer, respectively, and used as an experimental group; one cheek and canthus of volunteers who did not use the anti-aging skin care emulsion prepared according to the present invention were used as a control group.
The volunteers applied the anti-aging skin care emulsion prepared in the embodiment once in the morning and at night every day, the service cycle was 4 weeks, and no other cosmetics were used in the test cycle. Then, the anti-aging skin care lotion prepared in this example was comparatively analyzed for skin elasticity and wrinkle improvement of volunteers using a skin elasticity tester and a facial wrinkle imager, and the results are shown in table 28:
watch 28
Detecting items | Anti-aging skin care lotion |
Wrinkle (wrinkle) | Compared with the control group, the wrinkle depth of the experimental group becomes shallow, and the effect is very obvious |
Elasticity of skin | Compared with the control group, the skin elasticity of the experimental group is obviously improved |
The results show that the anti-aging skin care lotion prepared by the embodiment has very good effects of resisting wrinkles and improving skin elasticity.
Example 16
Examples of cosmetic preparations
The present invention provides several compositions for topical application, particularly for acne.
(1) The formulation of the cleansing cream is shown in table 29:
watch 29
Raw material/brand name | % |
Pure water | QSP 100% |
Allan with En (Arlatone) | 10-30% |
Cococo glucoside | 5-20% |
Hydroxypropyl guar gum | 1-5% |
Octanoyl glycine | 0-2% |
Nipagin ester | 0-2% |
Citronellol | 0-1% |
Citric acid | 0-1% |
Zinc PCA | 0-1% |
Fuzhuan tea extract | 0.01-5% |
(2) The proportions of sebum-regulating anti-acne emulsions are shown in table 30:
watch 30
(3) The formulation of the anti-inflammatory anti-acne emulsion is shown in table 31:
watch 31
(4) The formulation of the restorative anti-acne emulsion is shown in table 32:
watch 32
Raw material/brand name | % |
PEG40 stearate | 1%-5% |
PEG5 Glycerol stearate | 1%-5% |
Earth wax | 1%-5% |
Glyceryl monostearate | 1%-5% |
Sorbitan stearate | 0%-2% |
Cetyl alcohol | 0%-2% |
Malic acid hydrogen ester alcohol | 5%-20% |
Vitamin E | 0%-1% |
Panthenol | 0%-5% |
Maca peptide extract | 1%-5% |
Fuzhuan tea extract | 0.01%-5% |
Butanediol | 1%-5% |
Piroctone olamine | 0%-1% |
Nipagin ester | 0%-1% |
Glycerol | 1%-10% |
Xanthan gum | 0%-1% |
Zinc PCA | 0%-2% |
Rice starch | 1%-5% |
Nylon 6 | 0%-2% |
Polyacrylamide gel | 1%-5% |
Vitamin B6 | 0%-1% |
Citronellol | 0%-1% |
Pure water | QSP100% |
(5) The formulation of the anti-acne cream for regulating the stratum corneum is shown in table 33:
watch 33
(6) The anti-aging and anti-acne emulsion is shown in Table 34:
watch 34
(7) The formulation of the antibacterial anti-acne roll-on stick (stick roll-on) is shown in table 35:
watch 35
Raw material/brand name | % |
Castor oil | QSP 100% |
Oleyl alcohol | 10%-20% |
Palm oil | 10%-20% |
Polyglycerol-3-beeswax | 10%-20% |
Candelilla wax | 10%-20% |
Hectorite (hectorite) | 10%-20% |
Titanium dioxide | 0%-5% |
Fuzhuan tea extract | 0.01%-5% |
Asiatic fat of snow | 0%-5% |
Vitamin E | 0%-1% |
(8) The formula of SPF 50+ anti-acne sunscreen is shown in table 36:
watch 36
(9) The formula of the SPF 50+ anti-acne sunscreen spray is shown in table 37:
watch 37
(10) The compounding ratio of liniment 1 is shown in table 38:
watch 38
Raw material/brand name | % |
Arlatone duo (A La Tong Enduo) | 5%-20% |
Malic acid | 1%-10% |
Sclerotium rolfsii gum | 1%-10% |
Nipagin ester | 0%-1% |
Octanoyl glycine | 0%-1% |
Soda ash | 0%-1% |
Fuzhuan tea extract | 0.01%-5% |
Acid sodium pyrophosphate | 0%-1% |
Citric acid | 0%-1% |
Pure water | QSP 100% |
Citronellol | 0%-1% |
(11) The following is the formulation of a specific formula of the liniment, as shown in table 39:
watch 39
Raw material/brand name | % |
Arlatone duo (A La Tong Enduo) | 30% |
Chinese gum | 0.2% |
Glycerol (99%) | 2% |
Nipagin ester | 0.2% |
Sunflower oil | 2% |
Citronellol | 0.2% |
Fuzhuan tea extract | 3.4% |
Deionized water | 62% |
The preparation method of the liniment comprises the following steps:
1) heating deionized water to 80 deg.C, dispersing xanthan gum in water phase, and stirring.
2) Slowly stirring and adding Arlatone duo; the temperature was maintained at 75 ℃ with constant stirring, so that the starting material was uniformly dispersed.
3) Adding glycerol, stirring, and cooling.
4) When the temperature is reduced to 35 ℃, the tuckahoe tea extract, the nipagin ester, the sunflower oil and the citronellol are added to complete the preparation of the anti-aging liniment.
40 volunteers were selected and randomized for gender. The anti-aging liniment prepared in the embodiment is respectively and randomly applied to one of the left cheek or the right cheek and one of the left canthus and the right canthus of each volunteer, and is used as an experimental group; one cheek and canthus of the volunteer who did not use the anti-aging liniment prepared by the invention served as a control group.
The anti-aging liniment prepared by the embodiment is applied to volunteers in the morning and at night every day, the use period is 8 weeks, and other cosmetics cannot be used in the test period. Then, the liniment prepared in this example was comparatively analyzed for the skin elasticity and wrinkle improvement of volunteers by using a skin elasticity tester and a facial wrinkle imager, and the results are shown in table 40:
watch 40
Detecting items | Anti-aging liniment |
Wrinkle (wrinkle) | Compared with the control group, the wrinkle depth of the experimental group becomes shallow, and the effect is very obvious |
Elasticity of skin | Compared with the control group, the skin elasticity of the experimental group is obviously improved |
The result shows that the anti-aging liniment prepared by the embodiment has very good effects of resisting wrinkles and improving the skin elasticity.
Example 17
Preliminary study of Fuzhuan tea extract components: the Jingyang Fuzhuan tea 16KG was pulverized, and 300g of the Fuzhuan tea extract was extracted by the method described in example 1.
Dispersing the Fuzhuan tea extract in 1000mL of distilled water, fully extracting by using petroleum ether, ethyl acetate and n-butyl alcohol in sequence, and carrying out column chromatography on the total extract to obtain a segmented product: petroleum ether extract (2g), ethyl acetate extract (70g), n-butanol extract (81g), and water extract (40g) with small polarity to large polarity.
Example 18
The preparation method of the fu tea organic solvent extract comprises the following steps: grinding Fuzhuan tea into powder, wherein the diameter of tea powder is not more than 0.5cm, adding 85% -95% ethanol into the Fuzhuan tea powder according to the solid-to-liquid ratio of 1:20(m/v), and performing ultrasonic wall breaking until the tea powder and thalli are not visible to naked eyes. Then cold soaking for 18-28 hours, collecting filtrate, repeating for 2-5 times, distilling the filtrate under reduced pressure, concentrating the filtrate, drying at low temperature to obtain crude extract, adsorbing and decolorizing the crude extract by macroporous resin (AB-8 macroporous adsorption resin, Donghong chemical industry), eluting by 85% -95% ethanol, concentrating and evaporating to dryness, and freeze-drying at low temperature to obtain the fu tea organic solvent extract.
Example 19
The preparation method of the Fuzhuan tea water extract comprises the following steps: grinding Fuzhuan tea into powder, wherein the diameter of the tea powder is not more than 0.5cm, adding water into the Fuzhuan tea powder according to the solid-to-liquid ratio of 1:10(m/v), stirring uniformly, and performing ultrasonic wall breaking until the tea powder and the bacteria are not visible to naked eyes. Then standing for 2 hours at room temperature, and boiling for 2 hours in a boiling water bath to obtain a mixed solution; taking out the mixed solution, cooling, centrifuging at an ultra-high speed, and taking a supernatant; filtering and sterilizing the supernatant with 0.22 μm filter membrane to obtain water extract of Fuzhuan tea. Concentrating and evaporating to dryness if necessary, and freeze-drying at low temperature.
Although the present invention has been described with reference to a preferred embodiment, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (4)
1. Use of an extract of Fuzhuan tea in the preparation of a skin conditioning product, wherein the skin conditioning product comprises a cosmetic, nutraceutical, dermatological use product against acne;
the Fuzhuan tea extract is supercritical CO2Extracting the extract;
the supercritical CO2The preparation method of the extract comprises the following steps: grinding Fuzhuan tea into powder with diameter not more than 0.5cm, completely crushing tea powder and thallus, adding water vapor for pre-soaking until water content is increased to 40%, placing the pre-soaked Fuzhuan tea powder into an extraction tank, and continuously feeding CO into the tank2Gradually extracting the crude extract with CO of the crude extract2Sending to a cleaning tank, allowing the Fuzhuan tea extract to enter water phase, and passing through supercritical CO2Extracting to produce a crude extract, hydrolyzing the starch and fiber with a mixture of cellulase and alpha-amylase, treating the mixture at 65 deg.C for 30 minutes to denature the enzyme, and centrifuging to remove impurities; removing residual proteins by using a 15kDa ultrafiltration column, bleaching the extract with activated carbon and subsequently filtering and returningCollecting, filtering the product with 0.2 μm filter membrane for sterilization, and lyophilizing or packaging to obtain Fuzhuan tea supercritical CO2And (3) extracting.
2. Use of a fu tea extract according to claim 1 for the preparation of a skin conditioning product, characterized in that the dermatological use product is a dermatological use product against acne.
3. Use of a fu tea extract in the manufacture of a skin conditioning product according to claim 2, wherein the fu tea extract inhibits inflammation by a specific effect against propionibacterium acnes for use as a skin conditioning product.
4. The use of a Fuzhuan extract in the preparation of a skin conditioning product according to claim 1, wherein the skin conditioning product comprises the Fuzhuan extract as the only active ingredient or a pharmaceutical composition comprising the Fuzhuan extract.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111073906.2A CN113694115A (en) | 2019-11-28 | 2019-12-18 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
PCT/CN2020/131242 WO2021104276A1 (en) | 2019-11-28 | 2020-11-24 | Uses of fu tea extract in preparing skin-conditioning product |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911191700 | 2019-11-28 | ||
CN2019111917002 | 2019-11-28 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111073906.2A Division CN113694115A (en) | 2019-11-28 | 2019-12-18 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111053716A CN111053716A (en) | 2020-04-24 |
CN111053716B true CN111053716B (en) | 2021-12-03 |
Family
ID=70302261
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111073906.2A Pending CN113694115A (en) | 2019-11-28 | 2019-12-18 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
CN201911306311.XA Active CN111053716B (en) | 2019-11-28 | 2019-12-18 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111073906.2A Pending CN113694115A (en) | 2019-11-28 | 2019-12-18 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN113694115A (en) |
WO (1) | WO2021104276A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113694115A (en) * | 2019-11-28 | 2021-11-26 | 沣潮医药科技(上海)有限公司 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
CN111961702A (en) * | 2020-07-22 | 2020-11-20 | 上海珈蓓生物科技有限公司 | Cytological evaluation method for anti-skin infectious inflammatory reaction of plant extract and application thereof |
CN113332199A (en) * | 2021-06-03 | 2021-09-03 | 上海辉文生物技术股份有限公司 | Tea fermentation extracting solution with anti-aging function and skin microcirculation improving function and application thereof |
CN114796087B (en) * | 2022-03-08 | 2023-06-13 | 广州市尚梓化工科技有限公司 | Preparation method of sea fennel stem cell extract and application of sea fennel stem cell extract in cosmetics |
CN115589946A (en) * | 2022-10-18 | 2023-01-13 | 安赛搏(重庆)生物技术有限公司(Cn) | Preparation method and application of desert rose leaf callus extract |
CN118325737A (en) * | 2023-02-09 | 2024-07-12 | 西安巨子生物基因技术股份有限公司 | Eurotium cristatum fermentation preparation with acne resisting effect and application thereof |
CN116270340B (en) * | 2023-02-13 | 2024-08-16 | 佛山市奥姿美生物科技有限公司 | Preparation method and application of efficient-permeation soothing and anti-aging composition |
CN117159421A (en) * | 2023-08-31 | 2023-12-05 | 西北大学 | Selenium-rich Fu tea extract, preparation method thereof and application thereof in preparing whitening and freckle removing agent |
CN117417408B (en) * | 2023-12-14 | 2024-02-13 | 深圳市维琪科技股份有限公司 | Anti-aging hexapeptide, composition and application thereof |
CN118662383A (en) * | 2024-05-10 | 2024-09-20 | 四平华科生物技术有限责任公司 | SOD complex enzyme, preparation method thereof and application thereof in dermatological product treatment |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753527A (en) * | 2016-08-17 | 2018-03-06 | 宋福行 | Fu tea extractions and its application in regulation blood fat and liver fat |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101999491A (en) * | 2010-09-13 | 2011-04-06 | 长沙朗林生物制品有限公司 | Process method for extracting tea polyphenol from Fuzhuan tea |
CN106309235B (en) * | 2016-09-22 | 2019-06-07 | 陕西科技大学 | A kind of shampoo and preparation method thereof |
CN107494836A (en) * | 2017-10-06 | 2017-12-22 | 佛山文森特知识产权服务有限公司 | A kind of Fu tea anti-ageing healthcare cream |
CN108077484A (en) * | 2017-11-16 | 2018-05-29 | 泾阳雪瑞安商贸有限公司 | The formula of Fu-brick tea collagen ginseng mixed plant drink |
CN108925803A (en) * | 2018-06-20 | 2018-12-04 | 西安巨子生物基因技术股份有限公司 | A kind of preparation method of the coronoid process dissipate capsule bacterium functional beverage with aroma type |
CN110478261A (en) * | 2019-09-17 | 2019-11-22 | 大连民族大学 | A kind of dark green tea facial mask with beauty and skin care |
CN113694115A (en) * | 2019-11-28 | 2021-11-26 | 沣潮医药科技(上海)有限公司 | Application of Fuzhuan tea extract in preparation of skin conditioning product |
-
2019
- 2019-12-18 CN CN202111073906.2A patent/CN113694115A/en active Pending
- 2019-12-18 CN CN201911306311.XA patent/CN111053716B/en active Active
-
2020
- 2020-11-24 WO PCT/CN2020/131242 patent/WO2021104276A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753527A (en) * | 2016-08-17 | 2018-03-06 | 宋福行 | Fu tea extractions and its application in regulation blood fat and liver fat |
Non-Patent Citations (1)
Title |
---|
喝不完的茯茶水别倒掉 它能让你皮肤变白皙;京众康茯茶;《blog.sina.com.cn/s/blog_152ecb8330102w7u9.html》;20151013;第1页第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN113694115A (en) | 2021-11-26 |
WO2021104276A1 (en) | 2021-06-03 |
CN111053716A (en) | 2020-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111053716B (en) | Application of Fuzhuan tea extract in preparation of skin conditioning product | |
US11026441B2 (en) | Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same | |
US10688142B2 (en) | Methods of treatment using a lipid extract of Passiflora seeds concentrated in its unsaponifiable fraction | |
EP2459161B1 (en) | Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra sphenanthera | |
KR101760959B1 (en) | Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same | |
TWI381834B (en) | Abnormal protein removal composition | |
KR101567129B1 (en) | Acacia macrostachya seed extract and compositions containing same | |
WO2021104214A1 (en) | Use of exosome derived from carcass in skin regulation product | |
KR102239121B1 (en) | Sugar-free pineapple extract, method for producing the extract, and application of the extract | |
KR101059471B1 (en) | Cosmetic composition for skin aging | |
KR20190005369A (en) | Composition for preventing or improving skin wrinkle comprising c-phycocyanin as effective component | |
JP2008201773A (en) | External preparation for skin | |
JP2017214349A (en) | Cosmetic and Oral Composition | |
JP6482930B2 (en) | Skin cosmetics and foods and drinks | |
JP6055667B2 (en) | Collagen production promoter | |
TW202102239A (en) | Antiaging agent, antioxidant, antiinflammatory agent and whitening agent, and cosmetic | |
CN110403890A (en) | Composition for skin beauty including sturgeon roe extract and sturgeon amniotic fluid extract | |
KR102343112B1 (en) | Anti-aging composition comprising functional peptides, amino acids, callus extract and fermented materials | |
CN107427453B (en) | Peptide and glycoside extract of fructus Schisandrae chinensis fruit and its effect in improving skin nervous system response | |
JP4247091B2 (en) | Skin anti-aging agent | |
JP6827691B2 (en) | Cosmetics | |
KR102290291B1 (en) | Composition for improving moisturizing skin containing fermented blueberry and black rice extracts | |
KR20210123548A (en) | Improvement composition for Hot flash comprising the extract of Salvia miltiorrhiza as an active ingredient | |
KR20170136923A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20220152929A (en) | Cosmetic composition for improving atopy comprising angelica tenuissima fermented extracts as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |